Repare Therapeutics’ Post

View organization page for Repare Therapeutics, graphic

14,312 followers

CONFERENCE UPDATE: The abstract is available for Repare Therapeutics' presentation at ESMO GI from the Phase 1 MINOTAUR trial evaluating lunresertib in combination with FOLFIRI. Learn more here: https://lnkd.in/ebPvugmb #precisiononcology #syntheticlethality #clinicaltrials

  • No alternative text description for this image
Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies.

4w

Congratulations on sharing the abstract for your presentation at ESMO GI, Repare Therapeutics! The Phase 1 MINOTAUR trial's evaluation of lunresertib in combination with FOLFIRI sounds promising in advancing precision oncology. Wishing you great success as you continue to contribute to the field of synthetic lethality and clinical trials. Looking forward to learning more about your findings! 🌟 #PrecisionOncology #ClinicalResearch #ESMOGI

Like
Reply
Darwin Ye

Penn Ph.D | Parker Institute for Cancer Immunotherapy

4w

Looking forward to this!

Gagan Kukreja

Associate Director, Medicinal Chemistry, SynVent IDD, Syngene

4w

Really encouraging. Best Wishes for the journey ahead.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics